- Home
- BNTX vs LI Comparison
BNTX vs LI Comparison
Compare BNTX & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- LI
- Stock Information
- Founded
- BNTX 2008
- LI 2015
- Country
- BNTX Germany
- LI China
- Employees
- BNTX N/A
- LI N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- LI Auto Manufacturing
- Sector
- BNTX Health Care
- LI Consumer Discretionary
- Exchange
- BNTX Nasdaq
- LI Nasdaq
- Market Cap
- BNTX 23.9B
- LI 28.7B
- IPO Year
- BNTX 2019
- LI 2020
- Fundamental
- Price
- BNTX $114.13
- LI $24.44
- Analyst Decision
- BNTX Strong Buy
- LI Buy
- Analyst Count
- BNTX 15
- LI 6
- Target Price
- BNTX $143.50
- LI $36.43
- AVG Volume (30 Days)
- BNTX 659.5K
- LI 5.3M
- Earning Date
- BNTX 11-04-2024
- LI 10-31-2024
- Dividend Yield
- BNTX N/A
- LI N/A
- EPS Growth
- BNTX N/A
- LI 56.67
- EPS
- BNTX N/A
- LI 1.37
- Revenue
- BNTX $3,390,698,192.00
- LI $20,232,143,532.00
- Revenue This Year
- BNTX N/A
- LI $19.64
- Revenue Next Year
- BNTX N/A
- LI $31.36
- P/E Ratio
- BNTX N/A
- LI $17.89
- Revenue Growth
- BNTX N/A
- LI 42.25
- 52 Week Low
- BNTX $76.53
- LI $17.44
- 52 Week High
- BNTX $131.49
- LI $46.44
- Technical
- Relative Strength Index (RSI)
- BNTX 49.15
- LI 58.31
- Support Level
- BNTX $109.52
- LI $21.58
- Resistance Level
- BNTX $115.34
- LI $23.99
- Average True Range (ATR)
- BNTX 4.74
- LI 0.58
- MACD
- BNTX -0.80
- LI 0.28
- Stochastic Oscillator
- BNTX 29.03
- LI 78.14
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 376,000 NEVs in 2023, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.